About Sexton Biotechnologies
Sexton Biotechnologies is a company based in Indianapolis (United States) founded in 2019 by Monica Wight and Vicky Tran was acquired by BioLife Solutions in August 2021.. Sexton Biotechnologies has raised $5 million across 1 funding round from investors including BioLife Solutions. Sexton Biotechnologies offers products and services including CryoStor, HypoThermosol, and Stemulate hPL. Sexton Biotechnologies operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Indianapolis, United States
- Founders Monica Wight, Vicky Tran
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biolife Solutions Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 1 rounds
-
Latest Funding Round
$5 M (USD), Series A
Oct 23, 2019
- Investors
-
Employee Count
Employee Count
-
Acquired by
BioLife Solutions
(Aug 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sexton Biotechnologies
Sexton Biotechnologies offers a comprehensive portfolio of products and services, including CryoStor, HypoThermosol, and Stemulate hPL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Media for cryopreservation of biologics at low temperatures.
Solution for hypothermic storage and shipping of cells.
Platelet lysate for improving cell growth in research.
Funding Insights of Sexton Biotechnologies
Sexton Biotechnologies has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.0M
-
First Round
First Round
(23 Oct 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series A - Sexton Biotechnologies | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sexton Biotechnologies
Sexton Biotechnologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioLife Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sexton Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sexton Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sexton Biotechnologies Comparisons
Competitors of Sexton Biotechnologies
Sexton Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Online platform offering life sciences reagents and kits
|
|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sexton Biotechnologies
Frequently Asked Questions about Sexton Biotechnologies
When was Sexton Biotechnologies founded?
Sexton Biotechnologies was founded in 2019.
Where is Sexton Biotechnologies located?
Sexton Biotechnologies is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Is Sexton Biotechnologies a funded company?
Sexton Biotechnologies is a funded company, having raised a total of $5M across 1 funding round to date. The company's 1st funding round was a Series A of $5M, raised on Oct 23, 2019.
What does Sexton Biotechnologies do?
Sexton Biotechnologies was founded in 2019 in Indianapolis, United States, with a focus on biotechnology for pharmaceutical applications. A portfolio of solutions is provided, including T-Liven PR for enhancing T-cell functions in vitro and in vivo, human platelet lysate, an automated filling system known as AF-500, and cryogenic CellSeal vials. Operations center on process and handling tools for pharma companies and labs.
Who are the top competitors of Sexton Biotechnologies?
Sexton Biotechnologies's top competitors include Biocare Medical, Merck and Siemens Healthineers.
What products or services does Sexton Biotechnologies offer?
Sexton Biotechnologies offers CryoStor, HypoThermosol, and Stemulate hPL.
Who are Sexton Biotechnologies's investors?
Sexton Biotechnologies has 1 investor. Key investors include BioLife Solutions.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.